KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survival

Journal:
Science Advances
Published:
DOI:
10.1126/sciadv.aea2106
Affiliations:
6
Authors:
17
Go to article
Institutions Authors Share
Bosch, Germany
11.000000
11.000000
 0.65
Mayo Clinic, United States of America (USA)
3.500000
 0.21
University of Tübingen (Uni Tübingen), Germany
1.500000
 0.09
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology (IKP), Germany
1.000000
 0.06
Interested in Oncology and Carcinogenesis?